X
BEAM icon

Xponance’s Beam Therapeutics BEAM Stock Holding History

Xponance’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
9,069
+1,495
+20% +$41.5K ﹤0.01% 1436
2025
Q4 		$210K Buy
+7,574
New +$193K ﹤0.01% 1369
2021
Q4 		– Sell
-2,342
Closed -$204K – 1176
2021
Q3 		$204K Sell
2,342
-230
-9% -$23.1K ﹤0.01% 1116
2021
Q2 		$331K Buy
+2,572
New +$205K 0.01% 1050

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Xponance's BEAM Position: Q1 2026 in Review

Xponance increased its Beam Therapeutics (BEAM) stake by 20% in Q1 2026, buying an estimated $41.5K and bringing the position to 9,069 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Xponance first reported a position in BEAM in Q2 2021 and has held it in 4 quarters since. The position peaked at $331K in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Xponance held 9,069 shares of Beam Therapeutics worth $216K as of Q1 2026.
  • Xponance bought 1,495 Beam Therapeutics shares in Q1 2026, an estimated $41.5K.
  • Beam Therapeutics made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1436 holding.
  • Xponance first reported a position in Beam Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • Xponance's Beam Therapeutics position peaked at $331K in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.